Australian Clinical Labs Ltd (AU:ACL) has released an update.
JPMorgan Chase & Co. and its subsidiaries have ceased to be substantial holders in Australian Clinical Labs Ltd as of June 4, 2024, with changes in relevant interests including securities on loan, rehypothecation, and purchase and sales of securities. This move follows their last notice of substantial holding given on May 22, 2024, marking a significant shift in the company’s ownership structure.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
